| 2025年中报 | 2024年年报 | 2024年中报 | 2024年一季报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 防疫类(元) | 675,286,607.40 | 1,316,252,929.41 | 668,428,842.96 | 329,000,000.00 |
| 抗感染(元) | 2,594,100,609.55 | 4,982,385,336.60 | 2,722,838,219.05 | 1,371,000,000.00 |
| 农药、兽药类(元) | 364,354,430.50 | 765,345,105.32 | 413,011,448.66 | 201,000,000.00 |
| 神经、血液系统用药(元) | 132,532,046.39 | 264,313,659.10 | 121,774,804.59 | 55,000,000.00 |
| 肾病及免疫调节类(元) | 244,008,447.26 | 464,330,239.29 | 240,541,688.67 | 120,000,000.00 |
| 维生素及健康消费品(元) | 90,548,667.29 | 236,288,182.73 | 147,482,373.42 | 53,000,000.00 |
| 心脑血管类(元) | 170,693,042.60 | 285,565,461.52 | 153,176,327.98 | 67,000,000.00 |
| 医药中间体(元) | 341,277,434.90 | 615,038,955.73 | 217,596,742.82 | 100,000,000.00 |
| 医药及其他物流贸易(元) | 356,444,647.48 | 455,306,222.29 | 292,246,548.97 | 127,000,000.00 |
| 其他(元) | 259,468,985.13 | 412,987,569.52 | 226,883,242.41 | 122,000,000.00 |
| 营业成本(元) | ||||
| 防疫类(元) | 94,862,076.59 | 196,953,707.69 | 92,151,636.09 | 39,000,000.00 |
| 抗感染(元) | 2,067,266,217.22 | 3,948,946,270.21 | 2,172,319,854.82 | 1,090,000,000.00 |
| 农药、兽药类(元) | 314,192,439.75 | 656,315,016.45 | 354,391,828.92 | 169,000,000.00 |
| 神经、血液系统用药(元) | 71,640,331.21 | 105,239,572.45 | 57,557,371.81 | 28,000,000.00 |
| 肾病及免疫调节类(元) | 81,573,216.74 | 121,451,573.74 | 65,809,001.40 | 36,000,000.00 |
| 维生素及健康消费品(元) | 80,995,090.53 | 185,010,533.46 | 126,851,375.12 | 38,000,000.00 |
| 心脑血管类(元) | 76,989,001.31 | 138,058,768.24 | 83,774,965.82 | 46,000,000.00 |
| 医药中间体(元) | 293,217,177.92 | 522,884,148.96 | 206,313,450.09 | 85,000,000.00 |
| 医药及其他物流贸易(元) | 351,197,322.27 | 445,073,134.95 | 287,307,210.12 | 124,000,000.00 |
| 其他(元) | 248,992,274.67 | 361,221,496.64 | 200,410,092.91 | 113,000,000.00 |
| 毛利(元) | ||||
| 防疫类(元) | 580,424,530.81 | 1,119,299,221.72 | 576,277,206.87 | 290,000,000.00 |
| 抗感染(元) | 526,834,392.33 | 1,033,439,066.39 | 550,518,364.23 | 281,000,000.00 |
| 农药、兽药类(元) | 50,161,990.75 | 109,030,088.87 | 58,619,619.74 | 32,000,000.00 |
| 神经、血液系统用药(元) | 60,891,715.18 | 159,074,086.65 | 64,217,432.78 | 27,000,000.00 |
| 肾病及免疫调节类(元) | 162,435,230.52 | 342,878,665.55 | 174,732,687.27 | 84,000,000.00 |
| 维生素及健康消费品(元) | 9,553,576.76 | 51,277,649.27 | 20,630,998.30 | 15,000,000.00 |
| 心脑血管类(元) | 93,704,041.29 | 147,506,693.28 | 69,401,362.16 | 21,000,000.00 |
| 医药中间体(元) | 48,060,256.98 | 92,154,806.77 | 11,283,292.73 | 15,000,000.00 |
| 医药及其他物流贸易(元) | 5,247,325.21 | 10,233,087.34 | 4,939,338.85 | 3,000,000.00 |
| 其他(元) | 10,476,710.46 | 51,766,072.88 | 26,473,149.50 | 9,000,000.00 |
| 毛利率(%) | ||||
| 防疫类(%) | 85.95 | 85.04 | 86.21 | 88.15 |
| 抗感染(%) | 20.31 | 20.74 | 20.22 | 20.50 |
| 农药、兽药类(%) | 13.77 | 14.25 | 14.19 | 15.92 |
| 神经、血液系统用药(%) | 45.94 | 60.18 | 52.73 | 49.09 |
| 肾病及免疫调节类(%) | 66.57 | 73.84 | 72.64 | 70.00 |
| 维生素及健康消费品(%) | 10.55 | 21.70 | 13.99 | 28.30 |
| 心脑血管类(%) | 54.90 | 51.65 | 45.31 | 31.34 |
| 医药中间体(%) | 14.08 | 14.98 | 5.19 | 15.00 |
| 医药及其他物流贸易(%) | 1.47 | 2.25 | 1.69 | 2.36 |
| 其他(%) | 4.04 | 12.53 | 11.67 | 7.38 |
| 收入构成(%) | ||||
| 防疫类(%) | 12.91 | 13.43 | 12.84 | 12.93 |
| 抗感染(%) | 49.61 | 50.85 | 52.32 | 53.87 |
| 农药、兽药类(%) | 6.97 | 7.81 | 7.94 | 7.90 |
| 神经、血液系统用药(%) | 2.53 | 2.70 | 2.34 | 2.16 |
| 肾病及免疫调节类(%) | 4.67 | 4.74 | 4.62 | 4.72 |
| 维生素及健康消费品(%) | 1.73 | 2.41 | 2.83 | 2.08 |
| 心脑血管类(%) | 3.26 | 2.91 | 2.94 | 2.63 |
| 医药中间体(%) | 6.53 | 6.28 | 4.18 | 3.93 |
| 医药及其他物流贸易(%) | 6.82 | 4.65 | 5.62 | 4.99 |
| 其他(%) | 4.96 | 4.22 | 4.36 | 4.79 |
| 毛利构成(%) | ||||
| 防疫类(%) | 37.50 | 35.91 | 37.01 | 37.32 |
| 抗感染(%) | 34.04 | 33.16 | 35.36 | 36.16 |
| 农药、兽药类(%) | 3.24 | 3.50 | 3.76 | 4.12 |
| 神经、血液系统用药(%) | 3.93 | 5.10 | 4.12 | 3.47 |
| 肾病及免疫调节类(%) | 10.49 | 11.00 | 11.22 | 10.81 |
| 维生素及健康消费品(%) | 0.62 | 1.65 | 1.32 | 1.93 |
| 心脑血管类(%) | 6.05 | 4.73 | 4.46 | 2.70 |
| 医药中间体(%) | 3.11 | 2.96 | 0.72 | 1.93 |
| 医药及其他物流贸易(%) | 0.34 | 0.33 | 0.32 | 0.39 |
| 其他(%) | 0.68 | 1.66 | 1.70 | 1.16 |